Quality Assurance and Safety Monitoring Committee

The Siteman Cancer Center places the highest priority on ensuring the safety of patients participating in clinical trials. The Quality Assurance and Safety Monitoring Committee (QASMC) provides independent oversight and review of quality assurance audits, serious adverse events (SAE) reporting and interim safety and monitoring reports.

Members
Nancy Bartlett, MD, Chair, Medical Oncology
Maria Baggstrom, MD, Medical Oncology
Leigh Boehmer, PharmD, Pharmacy
Sean DeFrates, PharmD, BMT/Hematologic Malignancies
Hiram Gay, MD, Radiation Oncology
J. Philip Miller, AB, Biostatistics
Matthew Mutch, MD, General Surgery
Michael Naughton, MD, Medical Oncology

Last updated: 7/11/14